HOME
- Breaking
- Photos
- Video
- Crime
- Obituaries
- Weather
- Traffic
- Crosswords
- Sudoku
- Horoscopes
- Apps
Local
- L.A. Now
- Politics
- Crime
- Education
- O.C.
- Westside
- Neighborhoods
- Environment
- Obituaries
- Data & Maps
U.S.
- Politics
- Nation Now
- Politics Now
- Top of the Ticket
- Science
- Science Now
- Obituaries
- Religion
World
- World Now
- Afghanistan war
- Africa
- Americas
- Asia
- Europe
- Middle East
Business
- Money & Co.
- Technology
- Highway 1
- Company Town
- Personal Finance
- Jobs
- Real Estate
- Cars
Sports
- Sports now
- Lakers
- Clippers
- Dodgers
- Angels
- NFL
- Kings
- NHL/Ducks
- USC
- UCLA
- Preps
- Scores
Entertainment
- Awards: The Envelope
- Movies
- TV
- Music
- Celebrity
- Arts & Culture
- Industry
- Critics' Picks
- Comics
Health
- Science Now
- Medicine
- Fitness & Nutrition
- Mental Health
- Health Reform
- Mind & Body
Living
- Home
- Food
- Image
- Books
- L.A. Affairs
- Comics
- Reader Photos
Travel
- SoCal
- California
- Mexico
- Hawaii
- Las Vegas
- Europe
- Asia
- Australia
- Travel & Deal Blog
Opinion
- Editorials
- Op-Ed
- Letters
- Opinion L.A.
- Readers' Rep
Shop
- Daily Deals
- Travel Offers
- Coupons
- Weekly Circulars
- Offers & Deals
- Sports Gear
- LA Times Product
- See More
Membership Services
Jobs
Cars
Real Estate
Subscribe
Rentals
Weekly Circulars
Custom Publishing
Place Ad

Cortex Applies for Listing on Nasdaq

ORANGE COUNTY BRIEFLY

March 25, 2000|Dow Jones

Cortex Pharmaceuticals Inc., which has its stock trading over the counter, said Friday it has applied for listing on the Nasdaq market system. The Irvine neuroscience company said in a press release that it has been informed by Nasdaq that the review process may take six to eight weeks.